[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 758700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 68, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.83, "open": 3.84, "dayLow": 3.6255, "dayHigh": 3.8673, "regularMarketPreviousClose": 3.83, "regularMarketOpen": 3.84, "regularMarketDayLow": 3.6255, "regularMarketDayHigh": 3.8673, "payoutRatio": 0.0, "beta": 0.612, "forwardPE": -2.1017935, "volume": 2693, "regularMarketVolume": 2693, "averageVolume": 3512, "averageVolume10days": 4750, "averageDailyVolume10Day": 4750, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 145289056, "fiftyTwoWeekLow": 3.32, "fiftyTwoWeekHigh": 12.7, "priceToSalesTrailing12Months": 29.23321, "fiftyDayAverage": 4.48882, "twoHundredDayAverage": 5.440675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -15415869, "profitMargins": 0.0, "floatShares": 14882000, "sharesOutstanding": 36874600, "sharesShort": 40367, "sharesShortPriorMonth": 42600, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0011, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.097229995, "shortRatio": 14.97, "shortPercentOfFloat": 0.0023, "impliedSharesOutstanding": 37568600, "bookValue": 3.842, "priceToBook": 1.0065851, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54043000, "trailingEps": -1.86, "forwardEps": -1.84, "enterpriseToRevenue": -3.102, "enterpriseToEbitda": 0.256, "52WeekChange": -0.021012664, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 3.8673, "targetHighPrice": 18.325623, "targetLowPrice": 4.885442, "targetMeanPrice": 11.478826, "targetMedianPrice": 11.352118, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 149439008, "totalCashPerShare": 4.054, "ebitda": -60229000, "totalDebt": 2444000, "quickRatio": 13.959, "currentRatio": 14.305, "totalRevenue": 4970000, "debtToEquity": 1.726, "revenuePerShare": 0.146, "returnOnAssets": -0.21441999, "returnOnEquity": -0.33982, "grossProfits": -42534000, "freeCashflow": -35437248, "operatingCashflow": -59248000, "revenueGrowth": -1.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.3173, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1744401906, "regularMarketTime": 1744401600, "regularMarketChangePercent": 0.9738932, "regularMarketPrice": 3.8673, "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "marketState": "CLOSED", "cryptoTradeable": false, "postMarketChangePercent": 0.845553, "postMarketPrice": 3.9, "postMarketChange": 0.0327001, "regularMarketChange": 0.03730011, "regularMarketDayRange": "3.6255 - 3.8673", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3512, "fiftyTwoWeekLowChange": 0.5473001, "fiftyTwoWeekLowChangePercent": 0.16484943, "fiftyTwoWeekRange": "3.32 - 12.7", "fiftyTwoWeekHighChange": -8.8327, "fiftyTwoWeekHighChangePercent": -0.69548815, "fiftyTwoWeekChangePercent": -2.1012664, "earningsTimestamp": 1741294800, "earningsTimestampStart": 1741294800, "earningsTimestampEnd": 1741294800, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.86, "epsForward": -1.84, "epsCurrentYear": -1.47838, "priceEpsCurrentYear": -2.615904, "fiftyDayAverageChange": -0.62152004, "fiftyDayAverageChangePercent": -0.13845956, "twoHundredDayAverageChange": -1.5733747, "twoHundredDayAverageChangePercent": -0.28918743, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]